Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

54.09
Delayed Data
As of Feb 17
 +4.26 / +8.55%
Today’s Change
34.31
Today|||52-Week Range
67.74
+29.62%
Year-to-Date

Today’s Trading

Previous close49.83
Today’s open49.86
Day’s range49.09 - 54.23
Volume1,137,186
Average volume (3 months)771,168
Market cap$2.3B
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-60.95%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+18.22%
P/E ratioNM
Price/Sales23.36
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...+0.38+0.36%
SAGESAGE Therapeutics In...+2.23+3.55%
IRWDIronwood Pharmaceuti...+0.16+0.94%
ARRYArray Biopharma Inc+0.19+1.70%
Data as of 4:00pm ET, 02/17/2017

Financials

Last reporting date--
EPS forecast (this quarter)-$1.52
Annual revenue (last year)$69.9M
Annual profit (last year)-$198.5M
Net profit margin-283.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Chief Financial Officer
Andrew J. Hirsch
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs